Last update 01 Nov 2024
Chongqing Kerun Biopharm R&D Co., Ltd.
Last update 01 Nov 2024
Overview
Tags
Eye Diseases
Congenital Disorders
Endocrinology and Metabolic Disease
Biological products
Growth factors
Recombinant polypeptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
重组人神经生长因子滴眼液治疗神经营养性角膜炎的随机、双盲、安慰剂平行对照、多中心、Ib 期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter, phase Ib clinical trial of recombinant human nerve growth factor eye drops in the treatment of neurotrophic keratitis
重组人神经生长因子滴眼液在中国健康成年受试者中单次给药/多次给药的安全性、耐受性及药代动力学 Ia 期临床试验
[Translation] Phase Ia clinical trial of safety, tolerability and pharmacokinetics of single/multiple administration of recombinant human nerve growth factor eye drops in healthy Chinese adult subjects
在使用大剂量甲氨蝶呤化疗后出现甲氨蝶呤排泄延迟的骨肉瘤患者中评价注射用重组羧肽酶G2降低甲氨蝶呤血药浓度有效性和安全性的单臂、开放、多中心临床试验
[Translation] A single-arm, open-label, multicenter clinical trial to evaluate the efficacy and safety of recombinant carboxypeptidase G2 for injection in reducing the blood concentration of methotrexate in osteosarcoma patients with delayed methotrexate excretion after high-dose methotrexate chemotherapy
100 Clinical Results associated with Chongqing Kerun Biopharm R&D Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Chongqing Kerun Biopharm R&D Co., Ltd.
Login to view more data
100 Translational Medicine associated with Chongqing Kerun Biopharm R&D Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 22 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
10
1
Phase 1 Clinical
Phase 2 Clinical
1
1
Phase 3 Clinical
Other
3
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free